You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MAB 124I-omburtamab

Showing 301 - 306 of 306
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dermatomyositis Trial run by the NIAMS (h5G1.1-mAb)

Completed
  • Dermatomyositis
  • Bethesda, Maryland
    National Institute of Arthritis and Musculoskeletal and Skin Dis
Mar 3, 2008

Ovarian Tumors Trial in United States (oregovomab)

Terminated
  • Ovarian Neoplasms
  • Miami, Florida
  • +7 more
Dec 13, 2007

Ovarian Tumors Trial in Canada, United States (oregovomab)

Terminated
  • Ovarian Neoplasms
  • Newport Beach, California
  • +16 more
Dec 13, 2007

Ovarian Cancer Trial in United States (oregovomab)

Terminated
  • Ovarian Cancer
  • Huntsville, Alabama
  • +61 more
Dec 13, 2007

Ovarian Cancer Trial (oregovomab)

Terminated
  • Ovarian Cancer
  • (no location specified)
Dec 13, 2007

Rectal Cancer Dukes B, Dukes C Trial in Austria (Fluourouracil, Leucovorin, MAb 17-1A)

Terminated
  • Rectal Cancer Dukes B, Dukes C
  • Oberpullendorf, Burgenland, Austria
  • +7 more
Mar 31, 2006